photo walkheader_zpsd5bunpmi.png

Monthly Archives: February 2013

Avastin + Chemo for Advanced Pancreatic Cancer?

We’ve watched with interest as the pendulum has swung back and forth over the years on the possible efficacy of agents (for pancreatic cancer) that block Vascular Endothelial Growth Factor (VEGF), a molecule that mediates angiogenesis (the vascular growth that occurs in tumors). Bevacizumab, a monoclonal antibody to VEGF, is known as Avastin and is […]

Facebook
Facebook